SEC Form 4
IBEX Limited Common Shares (IBEX) insider trading
In the 12 months to Oct 26, 2026, 9 IBEX insiders reported open-market sales of $5.9M across 18 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $5.9M
- 18 filings · 9 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 7 of 18
- $2.3M of $5.9M sold (39%)
Who traded IBEX, and when
- Sale
- Sale, pre-arranged (10b5-1)
IBEX daily close from Oct 27, 2025 to Oct 26, 2026, between $26.40 and $47.23, last $46.90. 18 sale and 0 purchase filings by 9 insiders, marked at their filing dates. Robert Thomas Dechant, Chief Executive Officer: sold $2.3M across 6 filings, first filed Feb 18, 2026, last Sep 29, 2026. David Martin Afdahl, Chief Operating Officer: sold $1.1M across 2 filings, first filed Sep 10, 2026, last Sep 15, 2026. Julie K. Casteel, Chief Sales/Marketing Officer: sold $816.2K across 2 filings, first filed Jun 16, 2026, last Sep 16, 2026. Bruce Neil Dawson, Chief Sales and CS Officer: sold $577.5K across 1 filing, first filed May 13, 2026, last May 13, 2026. Christina Alice Trofimuk-O'Connor, Chief Legal Officer: sold $395.7K across 1 filing, first filed Sep 16, 2026, last Sep 16, 2026. Daniella Ballou-Aares, Director: sold $223.2K across 2 filings, first filed Apr 17, 2026, last Sep 16, 2026. 3 others: sold $445.2K across 4 filings, first filed May 29, 2026, last Sep 16, 2026.
Largest mark · tap a row for others
David Martin Afdahl · Chief Operating Officer
Filing 1 of 2 within a week · $1,082,491 total
Sale $649,009
17,500 shares at $37.09 avg
Filed Sep 10, 2026 · traded Sep 8
Pre-arranged (10b5-1) · close on filing date $37.26
Robert Thomas Dechant · Chief Executive Officer
Chief Executive Officer
$2.3M soldDavid Martin Afdahl · Chief Operating Officer
Chief Operating Officer
$1.1M soldJulie K. Casteel · Chief Sales/Marketing Officer
Chief Sales/Marketing Officer
$816.2K soldBruce Neil Dawson · Chief Sales and CS Officer
Chief Sales and CS Officer
$577.5K soldChristina Alice Trofimuk-O'Connor · Chief Legal Officer
Chief Legal Officer
$395.7K soldDaniella Ballou-Aares · Director
Director
$223.2K sold3 others
Combined, one mark per week
$445.2K soldOpen-market trades
18 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Robert Thomas Dechant | Chief Executive Officer | $2.3M | — | 6 | 47% of sales | |
| David Martin Afdahl | Chief Operating Officer | $1.1M | — | 2 | 100% of sales | |
| Julie K. Casteel | Chief Sales/Marketing Officer | $816.2K | — | 2 | — | |
| Bruce Neil Dawson | Chief Sales and CS Officer | $577.5K | — | 1 | — | |
| Christina Alice Trofimuk-O'Connor | Chief Legal Officer | $395.7K | — | 1 | — | |
| Daniella Ballou-Aares | Director | $223.2K | — | 2 | — | |
| Mingzhe Zhuang | Director | $221.4K | — | 1 | — | |
| Paul Joseph Inson | Chief People Officer | $191.1K | — | 2 | 48% of sales | |
| Patrick McGinnis | Director | $32.6K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Robert Thomas Dechant Chief Executive Officer | SalePre-arranged (10b5-1) | 5,000 | $45.02 | $225.1K | 257,011 | |
traded | Robert Thomas Dechant Chief Executive Officer | Sale | 25,000 | $39.99 | $999.7K | 262,011 | |
traded | Christina Alice Trofimuk-O'Connor Chief Legal Officer | Sale | 9,876 | $40.07 | $395.7K | 26,855 | |
traded | Daniella Ballou-Aares Director | Sale | 1,500 | $40.29 | $60.4K | 10,395 | |
traded | Julie K. Casteel Chief Sales/Marketing Officer | Sale | 17,474 | $40.41 | $706.1K | 100,814 | |
traded | Paul Joseph Inson Chief People Officer | Sale | 2,500 | $40.07 | $100.2K | 27,224 | |
traded | Mingzhe Zhuang Director | Sale | 5,522 | $40.10 | $221.4K | 2,813 | |
traded | David Martin Afdahl Chief Operating Officer | SalePre-arranged (10b5-1) | 10,819 | $40.07 | $433.5K | 129,187 | |
traded | Paul Joseph Inson Chief People Officer | SalePre-arranged (10b5-1) | 2,274 | $40.00 | $91.0K | 29,724 | |
traded | David Martin Afdahl Chief Operating Officer | SalePre-arranged (10b5-1) | 17,500 | $37.09 | $649.0K | 140,006 | |
traded | Julie K. Casteel Chief Sales/Marketing Officer | Sale | 3,600 | $30.61 | $110.2K | 117,594 | |
traded | Patrick McGinnis Director | Sale | 1,030 | $31.69 | $32.6K | 5,833 | |
traded | Robert Thomas Dechant Chief Executive Officer | Sale | 7,800 | $30.50 | $237.9K | 285,606 | |
traded | Bruce Neil Dawson Chief Sales and CS Officer | Sale | 18,389 | $31.40 | $577.5K | 61,895 | |
traded | Daniella Ballou-Aares Director | Sale | 6,500 | $25.05 | $162.8K | 10,643 | |
traded | Robert Thomas Dechant Chief Executive Officer | SalePre-arranged (10b5-1) | 6,000 | $28.46 | $170.8K | 275,406 | |
traded | Robert Thomas Dechant Chief Executive Officer | SalePre-arranged (10b5-1) | 12,000 | $29.56 | $354.8K | 281,406 | |
traded | Robert Thomas Dechant Chief Executive Officer | SalePre-arranged (10b5-1) | 12,000 | $29.80 | $357.6K | 293,406 |
GET /stocks/filings/vX/form-4?tickers=IBEX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"IBEX"
],
"issuer_cik": "0001720420",
"owner_cik": "0001298255",
"accession_number": "0001298255-26-000019",
"form_type": "4",
"filing_date": "2026-09-29",
"period_of_report": "2026-09-25",
"issuer_name": "IBEX Ltd",
"issuer_trading_symbol": "IBEX",
"owner_name": "Dechant Robert Thomas",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Shares",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-25",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 45.0191,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 257011,
"transaction_value": 225095.5,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Sales made pursuant to the Reporting Person's 10b5-1 Plan dated November 18, 2025."
},
{
"id": "F2",
"description": "This transaction was executed in multiple trades at prices ranging from $45.00 to $45.060; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."
}
]
},
{
"tickers": [
"IBEX"
],
"issuer_cik": "0001720420",
"owner_cik": "0001973685",
"accession_number": "0001973685-26-000007",
"form_type": "4",
"filing_date": "2026-09-16",
"period_of_report": "2026-09-15",
"issuer_name": "IBEX Ltd",
"issuer_trading_symbol": "IBEX",
"owner_name": "Ballou-Aares Daniella",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1500,
"transaction_price_per_share": 40.291,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 10395,
"transaction_value": 60436.49999999999,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 86 records
- Option exercises1 record
- Tax withholding32 records
- Tax withholding (sold to cover)3 records
- Grants and awards47 records
- Other3 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has IBEX Limited Common Shares' CEO sold stock?
Yes. Robert Thomas Dechant (CEO) sold 67,800 shares ($2.3M) between Feb 2026 and Sep 2026, $1.1M of it under a pre-arranged 10b5-1 plan.
How current is IBEX’s insider data?
These are IBEX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track IBEX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for IBEX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.